Literature DB >> 23125198

Angiogenic factors in preeclampsia and related disorders.

Ana Sofia Cerdeira1, S Ananth Karumanchi.   

Abstract

During fetal development, the human placenta undergoes high levels of both angiogenesis and vasculogenesis. Additionally, the developing placenta undergoes a process of vascular mimicry (referred to as pseudovasculogenesis) as cytotrophoblasts convert from an epithelial to an endothelial phenotype. The initiation, maturation, and maintenance of the placental vasculature are of critical importance. Failure to do so can lead to adverse obstetric outcomes such as preeclampsia and/or intrauterine growth restriction (IUGR). Furthermore, the foundation of many aspects of adult health is laid in utero. In this context, normal placental function is not only critical for normal fetal development but can also permanently influence long-term health and disease. Understanding the mechanisms that regulate placental vasculogenesis and angiogenesis is therefore of critical importance. This chapter will focus on placental vascular development with a particular emphasis on the role of angiogenic factors in the pathogenesis of the maternal syndrome of preeclampsia and related disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23125198      PMCID: PMC3543100          DOI: 10.1101/cshperspect.a006585

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  138 in total

Review 1.  Angiogenesis.

Authors:  J Folkman; Y Shing
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

2.  Pregnancy, preeclampsia, and the endothelial cell.

Authors:  T F Ferris
Journal:  N Engl J Med       Date:  1991-11-14       Impact factor: 91.245

3.  Preeclampsia: an endothelial cell disorder.

Authors:  J M Roberts; R N Taylor; T J Musci; G M Rodgers; C A Hubel; M K McLaughlin
Journal:  Am J Obstet Gynecol       Date:  1989-11       Impact factor: 8.661

4.  Early pregnancy wastage: relationship between chorionic vascularization and embryonic development.

Authors:  B H Meegdes; R Ingenhoes; L L Peeters; N Exalto
Journal:  Fertil Steril       Date:  1988-02       Impact factor: 7.329

5.  Fetal vasculogenesis and angiogenesis in human placental villi.

Authors:  R Demir; P Kaufmann; M Castellucci; T Erbengi; A Kotowski
Journal:  Acta Anat (Basel)       Date:  1989

6.  Role of insulin-like growth factors in embryonic and postnatal growth.

Authors:  J Baker; J P Liu; E J Robertson; A Efstratiadis
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

7.  A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting.

Authors:  T M DeChiara; A Efstratiadis; E J Robertson
Journal:  Nature       Date:  1990-05-03       Impact factor: 49.962

8.  Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts.

Authors:  A Gougos; S St Jacques; A Greaves; P J O'Connell; A J d'Apice; H J Bühring; C Bernabeu; J A van Mourik; M Letarte
Journal:  Int Immunol       Date:  1992-01       Impact factor: 4.823

9.  Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.

Authors:  S Cheifetz; T Bellón; C Calés; S Vera; C Bernabeu; J Massagué; M Letarte
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

10.  Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression.

Authors:  L Holmgren; A Glaser; S Pfeifer-Ohlsson; R Ohlsson
Journal:  Development       Date:  1991-11       Impact factor: 6.868

View more
  35 in total

1.  Association between preeclampsia and the CXC chemokine family (Review).

Authors:  Xijing Liu; L I Dai; Rong Zhou
Journal:  Exp Ther Med       Date:  2015-03-09       Impact factor: 2.447

Review 2.  Candidate Gene, Genome-Wide Association and Bioinformatic Studies in Pre-eclampsia: a Review.

Authors:  Semone Thakoordeen; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2018-08-29       Impact factor: 5.369

3.  Variants in the fetal genome near FLT1 are associated with risk of preeclampsia.

Authors:  Ralph McGinnis; Valgerdur Steinthorsdottir; Nicholas O Williams; Gudmar Thorleifsson; Scott Shooter; Sigrun Hjartardottir; Suzannah Bumpstead; Lilja Stefansdottir; Lucy Hildyard; Jon K Sigurdsson; John P Kemp; Gabriela B Silva; Liv Cecilie V Thomsen; Tiina Jääskeläinen; Eero Kajantie; Sally Chappell; Noor Kalsheker; Ashley Moffett; Susan Hiby; Wai Kwong Lee; Sandosh Padmanabhan; Nigel A B Simpson; Vivien A Dolby; Eleonora Staines-Urias; Stephanie M Engel; Anita Haugan; Lill Trogstad; Gulnara Svyatova; Nodira Zakhidova; Dilbar Najmutdinova; Anna F Dominiczak; Håkon K Gjessing; Juan P Casas; Frank Dudbridge; James J Walker; Fiona Broughton Pipkin; Unnur Thorsteinsdottir; Reynir T Geirsson; Debbie A Lawlor; Ann-Charlotte Iversen; Per Magnus; Hannele Laivuori; Kari Stefansson; Linda Morgan
Journal:  Nat Genet       Date:  2017-06-19       Impact factor: 38.330

Review 4.  Role of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry.

Authors:  Emily J Su
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

5.  Intraplacental gene therapy with Ad-IGF-1 corrects naturally occurring rabbit model of intrauterine growth restriction.

Authors:  Sundeep G Keswani; Swathi Balaji; Anna B Katz; Alice King; Khaled Omar; Mounira Habli; Charles Klanke; Timothy M Crombleholme
Journal:  Hum Gene Ther       Date:  2015-03       Impact factor: 5.695

6.  Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice.

Authors:  Jacqueline G Parchem; Keizo Kanasaki; Megumi Kanasaki; Hikaru Sugimoto; Liang Xie; Yuki Hamano; Soo Bong Lee; Vincent H Gattone; Samuel Parry; Jerome F Strauss; Vesna D Garovic; Thomas F McElrath; Karen H Lu; Baha M Sibai; Valerie S LeBleu; Peter Carmeliet; Raghu Kalluri
Journal:  J Clin Invest       Date:  2018-10-08       Impact factor: 14.808

7.  Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction.

Authors:  Vicki Plaks; Julie Rinkenberger; Joanne Dai; Margaret Flannery; Malin Sund; Keizo Kanasaki; Wei Ni; Raghu Kalluri; Zena Werb
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

8.  Expression of G-protein subunit α-14 is increased in human placentas from preeclamptic pregnancies.

Authors:  Ying-Jie Zhao; Qing-Yun Zou; Yan Li; Hui-Hui Li; Yan-Ming Wu; Xing-Fu Li; Kai Wang; Jing Zheng
Journal:  J Histochem Cytochem       Date:  2014-01-14       Impact factor: 2.479

Review 9.  Angiogenic factors in diagnosis, management, and research in preeclampsia.

Authors:  Sarosh Rana; S Ananth Karumanchi; Marshall D Lindheimer
Journal:  Hypertension       Date:  2013-10-28       Impact factor: 10.190

10.  ITE Suppresses Angiogenic Responses in Human Artery and Vein Endothelial Cells: Differential Roles of AhR.

Authors:  Yan Li; Kai Wang; Qing-Yun Zou; Yi-Zhou Jiang; Chi Zhou; Jing Zheng
Journal:  Reprod Toxicol       Date:  2017-10-03       Impact factor: 3.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.